BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12383724)

  • 1. Endocrine disruptors: can biological effects and environmental risks be predicted?
    Witorsch RJ
    Regul Toxicol Pharmacol; 2002 Aug; 36(1):118-30. PubMed ID: 12383724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated "4-phase" approach for setting endocrine disruption screening priorities--phase I and II predictions of estrogen receptor binding affinity.
    Shi L; Tong W; Fang H; Xie Q; Hong H; Perkins R; Wu J; Tu M; Blair RM; Branham WS; Waller C; Walker J; Sheehan DM
    SAR QSAR Environ Res; 2002 Mar; 13(1):69-88. PubMed ID: 12074393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenoestrogens: mechanisms of action and detection methods.
    Mueller SO
    Anal Bioanal Chem; 2004 Feb; 378(3):582-7. PubMed ID: 14564443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xenoestrogens: endocrine disrupting compounds].
    Wozniak M; Murias M
    Ginekol Pol; 2008 Nov; 79(11):785-90. PubMed ID: 19140503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances.
    Navas JM; Segner H
    Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens.
    Gutendorf B; Westendorf J
    Toxicology; 2001 Sep; 166(1-2):79-89. PubMed ID: 11518614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine disruptors: update on xenoestrogens.
    Degen GH; Bolt HM
    Int Arch Occup Environ Health; 2000 Sep; 73(7):433-41. PubMed ID: 11057411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.
    Mattison DR; Karyakina N; Goodman M; LaKind JS
    Crit Rev Toxicol; 2014 Sep; 44(8):696-724. PubMed ID: 25099693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells.
    Strunck E; Stemmann N; Hopert A; Wünsche W; Frank K; Vollmer G
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):73-81. PubMed ID: 11086226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts.
    Hong H; Tong W; Fang H; Shi L; Xie Q; Wu J; Perkins R; Walker JD; Branham W; Sheehan DM
    Environ Health Perspect; 2002 Jan; 110(1):29-36. PubMed ID: 11781162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems for risk assessment of endocrine-active estrogenic compounds.
    Safe SH; Pallaroni L; Yoon K; Gaido K; Ross S; McDonnell D
    Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):925-9. PubMed ID: 12634121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions.
    Takeyoshi M; Yamasaki K; Sawaki M; Nakai M; Noda S; Takatsuki M
    Toxicol Lett; 2002 Jan; 126(2):91-8. PubMed ID: 11751013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of mechanistic data in the toxicological evaluation of endocrine modulators.
    Degen GH; Janning P; Wittsiepe J; Upmeier A; Bolt HM
    Toxicol Lett; 2002 Feb; 127(1-3):225-37. PubMed ID: 12052662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a yeast estrogen screen in non-biomarker species Varicorhinus barbatulus fish with two estrogen receptor subtypes to assess xenoestrogens.
    Fu KY; Chen CY; Chang WM
    Toxicol In Vitro; 2007 Jun; 21(4):604-12. PubMed ID: 17258427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocrine and reproductive system: adverse effects of hormonally active substances?
    Greim HA
    Pediatrics; 2004 Apr; 113(4 Suppl):1070-5. PubMed ID: 15060201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens.
    Fang H; Tong W; Shi LM; Blair R; Perkins R; Branham W; Hass BS; Xie Q; Dial SL; Moland CL; Sheehan DM
    Chem Res Toxicol; 2001 Mar; 14(3):280-94. PubMed ID: 11258977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a marker of exposure to xenoestrogen mixtures in human serum.
    Soto AM; Fernandez MF; Luizzi MF; Oles Karasko AS; Sonnenschein C
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):647-54. PubMed ID: 9168009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphibians as a model to study endocrine disruptors: I. Environmental pollution and estrogen receptor binding.
    Lutz I; Kloas W
    Sci Total Environ; 1999 Jan; 225(1-2):49-57. PubMed ID: 10028702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action.
    Rajapakse N; Silva E; Kortenkamp A
    Environ Health Perspect; 2002 Sep; 110(9):917-21. PubMed ID: 12204827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.
    Judson RS; Magpantay FM; Chickarmane V; Haskell C; Tania N; Taylor J; Xia M; Huang R; Rotroff DM; Filer DL; Houck KA; Martin MT; Sipes N; Richard AM; Mansouri K; Setzer RW; Knudsen TB; Crofton KM; Thomas RS
    Toxicol Sci; 2015 Nov; 148(1):137-54. PubMed ID: 26272952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.